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Role of homoeopathy in the management of adhesive capsulitis: A pretestposttest study
Abstract
Background
Background: Adhesive capsulitis (AC) is an insidious and painful stiffening of the glenohumeral (shoulder)
joint, resulting in compromised functional ability and quality of life (QoL).
Objectives
Objectives: Primary objective was to evaluate change in shoulder pain after individualised homoeopathy
treatment for over 2 months. Secondary objective was to assess the change in the QoL and outcome
related to impact on daily living (ORIDL).
Methods
Methods: A single-arm, pretest-posttest, clinical study on AC was conducted on 40 participants recruited
from the outpatient clinic of rheumatological disorders at Clinical Research Unit (Homoeopathy), Siliguri,
West Bengal, India. Medicines were prescribed on the basis of the totality of symptoms. Changes in
shoulder pain over 2 months were evaluated using the shoulder pain and disability index (SPADI). QoL
was evaluated using SF-12v2 and ORIDL (participants and physician assessed), respectively.
Results
Results: Thirty-six participants completed the study and four participants dropped out. A protocol
compliant sample of n = 36 was analysed. There was a statistically significant reduction of SPADI score
(91.92 ± 10.22 vs. 34.14 ± 24.43; mean reduction 57.78, 95% CI 49.41–66.14, P < 0.001) and statistically
significant increase in SF-12 v2 score (44.39 ± 9.70 vs. 72.27 ± 10.97; mean increase 27.87, 95% CI
23.89–31.85, P < 0.001). The Spearman’s correlation between the changes in physician assessment
ORIDL scores and participants assessment ORIDL scores over 2 months suggested a statistically
significant correlation (rs = 0.998, P < 0.01).
Conclusion
Conclusion: The findings showed symptom alleviation, and improvement in the QoL after homoeopathic
treatment. Randomised controlled trials are further warranted.
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Abstract
Background: Adhesive capsulitis (AC) is an insidious and painful stiffening of the glenohumeral (shoulder) joint, resulting in compromised
functional ability and quality of life (QoL). Objectives: Primary objective was to evaluate change in shoulder pain after individualised
homoeopathy treatment for over 2 months. Secondary objective was to assess the change in the QoL and outcome related to impact on
daily living (ORIDL). Methods: A single-arm, pretest-posttest, clinical study on AC was conducted on 40 participants recruited from
the outpatient clinic of rheumatological disorders at Clinical Research Unit (Homoeopathy), Siliguri, West Bengal, India. Medicines
were prescribed on the basis of the totality of symptoms. Changes in shoulder pain over 2 months were evaluated using the shoulder
pain and disability index (SPADI). QoL was evaluated using SF-12v2 and ORIDL (participants and physician assessed), respectively.
Results: Thirty-six participants completed the study and four participants dropped out. A protocol compliant sample of n = 36 was
analysed. There was a statistically significant reduction of SPADI score (91.92 ± 10.22 vs. 34.14 ± 24.43; mean reduction 57.78, 95%
CI 49.41–66.14, P < 0.001) and statistically significant increase in SF-12 v2 score (44.39 ± 9.70 vs. 72.27 ± 10.97; mean increase
27.87, 95% CI 23.89–31.85, P < 0.001). The Spearman’s correlation between the changes in physician assessment ORIDL scores and
participants assessment ORIDL scores over 2 months suggested a statistically significant correlation (rs = 0.998, P < 0.01). Conclusion:
The findings showed symptom alleviation, and improvement in the QoL after homoeopathic treatment. Randomised controlled trials
are further warranted.
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Introduction
Adhesive capsulitis (AC) (frozen shoulder) is a clinical
condition characterised by spontaneous onset of shoulder pain
and gradual loss of active and passive shoulder movements.[1]
The prevalence is more in women aged 40–60 years, diabetic
population with the occurrence rate of approximately 2–5% of
the general population,[2] and up to 20% in diabetics,[3] 13.4% of
participants with AC have thyroid dysfunction.[4] The incident of
AC in one shoulder increases the risk of contralateral shoulder
involvement by 5%–34%, and simultaneous bilateral shoulder
involvement develops in approximately 14% of cases.[5]
Zuckerman classified AC into primary and secondary
and subdivided the latter into intrinsic, extrinsic and
systemic ones.[6,7]
Participants presenting with AC often report an insidious
onset with a progressive increase in pain and a gradual
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decrease in active and passive range of motion (ROM).[5] The
subjects frequently have difficulty with dressing, grooming,
performing overhead reaching activities and particularly
fastening items behind the back for a period of several months
to several years.[7]
The literature reports that AC progresses through three
overlapping clinical phases that is, acute/freezing/painful
phase, adhesive/frozen/stiffening phase and resolution/thawing
phase.[8,9] The diagnosis of AC is usually based on clinical
findings, medical history and physical examination.[7] The
orthopaedic clinical examination for AC shows high sensitivity
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and specificity for the confident diagnosis of AC and is the
reference standard for diagnosis[10] Despite the value of
imaging techniques in recent advances, these are not initially
indicated to diagnose AC but can be used to rule out other intraarticular pathology[11] There is currently no gold standard for
diagnosis nor have validated diagnostic criteria been published
in the literature.[12]
Systemic reviews of the current therapies for AC such as
physiotherapy, both oral and intra-articular steroid, and
operative interventions do not provide significant long-term
benefits.[11] The Cochrane review also reports very inconclusive
results or add little evidence in interventions such as manual
therapy and acupuncture. Even though AC is a self -limiting
condition, lasting on an average for 2-3 years; few studies
have shown that 20-50 % of affected individuals do continue
to have pain and restricted movement beyond 3 years.[7] In
spite of this, recent clinical evidence of persistent functional
limitation, lasting for years, has challenged this theory.[13] A
2017 systematic review of seven studies found low-quality
evidence that no treatment yielded some, but not complete
improvement in ROM after 1–4 years of follow-up. Moderatequality evidence from three randomised controlled trials with
longitudinal data demonstrated that most improvement in pain
and ROM occurs early, not late.[14] Homoeopathic medicines
have been shown to provide relief and improve quality of
life (QoL) in rheumatic disorders such as fibromyalgia and
rheumatoid arthritis,[15-17] and could be a valid alternative
treatment for AC. [18] Unfortunately, there is inadequate
evidence to conclude the utility of individualised homoeopathic
medicine (IHM) in the management of AC. An observational
study of homoeopathy in AC by Magotra et al.[18] illustrates an
encouraging role with IHM having a positive treatment option
for AC. To further extrapolate the role of IHM in managing AC,
a study design incorporating an added outcome measurement
of QoL(SF-12) along with different study setting was devised.
Therefore, there was a need to explore the possible role of
IHM in relieving pain and stiffness, reduction in limitation and
disability in activities of daily life in the participants suffering
from AC. To generate such evidence, a preliminary singlegroup, pre-test, a post-test clinical study has been undertaken
by the investigators. The research question for this study was
the generated clinical hypothesis that whether 2 months of
(IHM) can significantly reduce pain, stiffness, limitation of
movements and improve QoL when measured on standardised
scales. The generated null hypothesis is that there is no statistical
significant difference of the shoulder pain and disability index
(SPADI) scores, SF-12v2 and outcome related to impact on
daily living (ORIDL) score of the patients between baseline
and after 2 months of homoeopathic treatment.

Methods
Setting and design

This was a prospective, single-group, pretest-posttest
clinical study conducted in the out patient department
of rheumatological disorders at Clinical Research Unit
32

(Homoeopathy), Siliguri, West Bengal, India from July 2019
to March 2020. The study protocol was approved by the
Institutional Ethics Committee, of Clinical Research Unit
(Homoeopathy), Siliguri, and was registered with the Clinical
Trials Registry – India (CTRI/2019/05/019121) before the
enrolment of the first participant. The proposed plan of work
adhered to the Declaration of Helsinki Ethical Principles for
Medical Research Involving Human Subjects adopted by the
18th WMA general assembly, Helsinki, Finland, June 1964.[19]
Each participant was provided with a participant information
sheet written in local vernacular Bengali language detailing
the objectives, methods, risks and benefits of participating and
confidentiality issues. Written informed consent was obtained
from each participant before the study participation.

Eligibility

Participants suffering from AC (ICD10-75.02) of painful and
stiffening phase of one or both shoulders were only included.
AC was clinically diagnosed, by assessing the shoulder pain
followed by gradual loss of both active and passive ROM of
the shoulders. Participants accompanying pain at the extreme
of motion observed mainly in the stiffness phase were also
included. Impaired ROM with forward flexion, abduction and
external and internal rotation was the prime clinical finding
in diagnosing AC.
Participants aged between 30 and 70 years old and who had
provided written informed consent were included in the study.
Excluded participants were those with severe degeneration of
the shoulder joint with marked joint narrowing with recent
shoulder surgery within the past 6 months, deformity of the
shoulder (>12°); evidenced by imaging or other evidence and
requiring surgical intervention, self-reported joint disorders
(e.g., inflammatory joint diseases, specific arthropathy, severe
axis deviations or instabilities, joint or skin infections and the
joint prosthesis of the upper limbs) other than AC. Exclusion
criteria also included those cases suffering from uncontrolled
systemic illness or life-threatening infections, those already
undergoing homeopathic treatment for any chronic disease
within past 3 months , who were compromised by substance
abuse and/or dependence, were pregnant or puerperal or
lactating women, patients with psychiatric diseases, and selfreported immune-compromised states.

Study procedures

As per the specified eligibility criteria, participants underwent
preliminary screening. Following this, a thorough case taking
was undertaken on a pre-designed case recording form. The
overall process of the selection of individualised medicine was
based on the presenting symptoms’ totality, repertorisation
and consultation with homoeopathic Materia Medica[20-24]
when required. On the whole, the decision-making was
influenced by two experienced practitioners after mutual
consensus. Successive prescriptions were generated following
the homoeopathic principles.[25] Symptoms considered for
the homoeopathic prescription and, in the subsequent visits,
the changes in these symptoms were mentioned clearly.
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Homoeopathic medicines, dilution methods, potency,
pharmaceutical form and dose were also recorded. All
medicines were procured from a GMP-certified firm: SBL
Pvt. Ltd. Each dose was directed to be taken orally on a clean
tongue. It consisted of four medicated sugar globules of size
30. Each participant enrolled was treated for 2 months, and
follow-up was done at every 2 weeks interval or earlier, as
and when required by the participants. Repetition was done
depending on the intensity of the complaints. The participants
were free to report on follow-up days, as mentioned above, in
person or by telephone as per convenience.

General management

All the participants were advised to maintain an ambulatory
state, avoid actions that can aggravate the pain and perform
joint mobility exercises.

Outcome assessment
Primary outcome

SPADI, a commonly used shoulder-specific health status
questionnaire[26,27] and described as the most responsive
shoulder pain and disability tool for shoulder conditions,[28]
was used in this study. It is ranked as one of the most relevant
questionnaires for shoulder pain for being easy to complete in
the least time that is, 2–5 min.[27,29] It consists of 13 items and
is divided into two constructs: Pain (5 items) and functional
disability (8 items). It is scored on an ordinal scale from 0
(no pain/no difficulty) to 10 (worst pain imaginable) with
higher scores indicating greater pain and/or disability.[27] SPADI
was assessed at baseline and after 2 months of intervention.

Secondary outcomes

The Short Form12 version 2 health survey (SF-12v2)
estimates eight domains of functioning and well-being of
respondents by considering their health status over the
past 4 weeks.[30] The SF-12 consists of 12 items and eight
subdomains: Physical functioning (PF), role physical (RP),
bodily pain (BP), general health (GH), vitality (VT), social
functioning (SF), role emotional (RE) and mental health
(MH). The subscales PF, RP, BP and GH form the physical
component summary (PCS-12) scores, whereas the subscales
VT, SF, RE and MH form the mental component summary
(MCS-12) scores.[31] Each item of the questionnaire has
response categories which vary from 2- to 6-point scales and
raw scores for items ranging from 1 to 6.[31] The raw scores
are summated and linearly transformed into 0–100 scale[31,32]
with a higher score indicating better health status.[31,32]
The clinical improvement and outcome of signs and symptoms
were assessed by ORIDL score[33] at every follow-up visit.
The ORIDL instrument records the assessment of response to
the previous prescription on the main complaint as well as on
general well-being on a numerical scale of –4 to +4.

Sample size

The sample size was calculated using the software G*Power
software (latest ver. 3.1.9.7; Heinrich-Heine-Universität
Düsseldorf, Düsseldorf, Germany; http://www.gpower.

hhu.de/)[34] Considering a chance to drop out of 20%, the
sample size was taken as 40. Therefore, we planned a
sample size of 40 participants to be recruited for this clinical
study. (The statistical analysis was performed by ‘t-test’ and
‘Difference between two dependent means (matched pairs)’
with ‘two tails test.’ The effect size was fixed at 0.5, alfa=0.05,
power [1-beta] = 0.8, degree of freedom was 1).

Statistical analysis

All statistical analyses were performed using Statistical
Package for the Social Sciences (SPSS), version 20.0
(IBM Corp., IBM SPSS Statistics for Windows, Armonk,
New York: USA). Per protocol (PP) analysis was performed
meaning only the protocol-compliant sample was used in
the final analysis. Data distribution for its normality was
examined by histograms, Q-Q plots and the Shapiro–Wilk
test. Descriptive data (categorical and continuous) were
presented in terms of absolute values, percentages, means
and standard deviations. Student’s t-test (parametric test)
was used as inferential statistics as per normality of data
distribution comparing dependent observation of continuous
outcomes at baseline and after 2 months. Pearson correlation
coefficient was measured to detect a correlation between
physician assessment score and participants’ assessment
score for ORIDL. P < 0.01 two tailed was considered as
statistically significant.

Results
A total of 70 participants reporting for pain in the shoulder were
preliminarily screened of which 30 (42.8%) were excluded;
40 met the eligibility criteria and were enrolled in the study.
Among those four participants dropped out and 36 completed
the study. The demographic details [Table 1] and the flow
diagram of participants [Figure 1] are given in the table and
figure, respectively.

Baseline features

The baseline sociodemographic features – age, gender,
residence, duration of illness, treatment history comorbidities,
marital status and educational status are shown in Table 1.

Test of normality of the data distribution

When histogram, Q-Q plot and Shapiro–Wilk test were carried
out, there was no significant departure from normality both in
terms of age and baseline data of SPADI and SF-12v2 data.

Pre-post comparison of outcome measures

The objective was to compare the mean scores of SPADI (pain,
disability and total) and of SF-12v2 (PCS, MCS and total) at
baseline and after 2 months of participants receiving IHT. The
data were analysed with the help of a correlated t-test and the
results are given in Table 2.
From Table 3, it can be seen that the t values of the primary
outcome measure of SPADI (pain, disability and total) and SF12v2 (PCS, MCS and total) are significant at 0.01 level with df
= 35. It indicates that mean scores of SPADI and SF-12v2 at pre-
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Table 1: Sociodemographic information at baseline
(n=40)
Variable

Table 2: Correlations between the changes in SPADI
total score and SF‑12 v2 overall score after 2 months of
treatment
Changes in SPADI
total score after
2 months of
treatment

Changes in SF‑12
v2 overall score
after 2 months of
treatment

Changes in SPADI
total score after 2
months of treatment
Pearson correlation
1
0.802**
Sig. (two tailed)
<0.001
36
36
n
Changes in SF‑12 v2
overall score after 2
months of treatment
Pearson correlation
0.802**
1
Sig. (two tailed)
<0.001
36
36
n
**Correlation is significant at the 0.01 level (two tailed)
34

Excluded (n = 30); reasons:
• Age beyond range (n = 5)
• Illiterate (n = 9)
• Not willing to participate and denied
consent (n = 3)
• Uncontrolled diabetes(n = 3)
• Uncontrolled hypertension(n = 4)
• Already undergoing medical
treatment for AC (n = 4)
• Deformity of the shoulder joint (n = 2)

Value n (%)

Age (in years)
*50.43 ± 12.10
Age group (in years)
30–40
10 (25.00)
41–50
13 (32.50)
Above 50
17 (42.50)
Duration of illness in months
3 (1–6)***
Duration of illness categorised
Up to 6 months
31 (77.50)
More than 6 months–1 year
6 (15.00)
More than 1 year–2 years
1 (2.50)
More than 2 years
2 (5.00)
Gender
Male
7 (17.50)
Female
33 (82.50)
Residence
Rural
30 (75.00)
Urban
10 (25.00)
Marital status
Married
30 (75.00)
Unmarried
1 (2.50)
Divorcee/widower
9 (22.50)
Comorbidity
Hypertension
12 (30.00)
Diabetes mellitus
4 (10.00)
Hypothyroidism
2 (5.00)
Tuberculosis
1 (2.50)
Others.
4 (10.00)
Education
Up to class 10
20 (50.00)
Up to class 12
8 (20.00)
Graduation and above
12 (30.00)
Data are presented as *mean±standard deviation, ***median (IQR)

Correlations

Screening as per eligibility criteria (n = 70)

Eligible participants (n = 40)
Received individualized homeopathy
(n = 40)
Drop out after
baseline (n = 4)
Followed up (n = 36)

Per protocol analysis (n = 36)

Figure 1: The participant flow diagram

test and post-test stages after IHT differ significantly. Therefore,
the null hypothesis that there is no significant difference in mean
scores of pain, limitation of movement and QoL at pre-test
and post-test stages after IHT is rejected. Further, the primary
outcome measure reductions in SPADI pain score (38.31 ±
4.11 vs. 15.61 ± 10.75; mean reduction 22.7, 95% CI 19.10–
26.29, P < 0.001), SPADI disability score (53.61 ± 7.25 vs.
18.53 ± 13.88; mean reduction 35.08, 95% CI 30.19–39.98, P <
0.001) and SPADI total score (91.92 ± 10.22 vs. 34.14 ± 24.43;
mean reduction 57.78, 95% CI 49.41–66.14, P < 0.001) were
statistically significant by parametric paired t-test [Table 3].
Secondary outcome measures – in SF-12 v2 health survey
increased in PCS score (41.43 ± 9.53 vs. 70.52 ± 12.58; mean
value increased 29.08, 95% CI 25.12–33.05, P < 0.001), MCS
score (49.72 ± 12.76 vs. 75.42 ± 8.89; mean value increased
25.69, 95% CI 21.13–30.25, P < 0.001) and overall score
(44.39 ± 9.70 vs. 72.27 ± 10.97; mean value increased 27.87,
95% CI 23.89–31.85, P < 0.001) were statistically significant
by parametric paired t-test [Table 3 ].
Table 2 shows that Pearson’s correlation coefficient is 0.802
which is positive and nearer to 1 and significant at the 0.01
level. It reflects that the changes in SPADI scores and SF12v2 overall scores over 2 months of IHT were positively and
significantly correlated [Figure 2].
Further, Table 4 reflects that there is a significant positive
correlation between ORIDL scores of the participants
assessment and the physician assessment with a correlation
coefficient of 0.998 significant at 0.01 level and df = 142.
To see the clinical significance between the baseline and
after 2 months of treatment, the effect size (Cohen’s-d) was
calculated from this primary outcome (SPADI score). The
obtained Cohen’s-d score (score ‘5.65’) [Table 3] indicates
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Table 3: Paired sample statistics
Variable

Mean±SD

Paired differences (baseline and 2 months)
Mean±SD

95% confidence interval of the difference

SPADI pain
Baseline
38.31±4.11
22.69±10.63
19.10–26.29
After 2 months
15.61±10.71
SPADI disability index
Baseline
53.61±7.25
35.08±14.48
30.19–39.98
After 2 months
18.53±13.88
SPADI total score
Baseline
91.92±10.22
57.78±24.72
49.41–66.14
After 2 months
34.14±24.43
SF‑12 v2, PCS‑12
Baseline
41.44±9.54
–29.09±11.72
–33.05––25.12
After 2 months
70.52±12.59
SF‑12 v2, MCS‑12
Baseline
49.72±12.76
–25.69±13.48
–30.25––21.13
After 2 months
75.42±8.89
SF‑12 v2, overall score
Baseline
44.39±9.71
–27.88±11.77
–31.86––23.89
After 2 months
72.27±10.98
Effect size (Cohen’s‑d)=Mean difference/SD=57.78/10.22=5.65. *P<0.05, significant at the 0.05 level (two tailed)

t

P‑value (two tailed)

12.805

0.000*

14.541

0.000*

14.026

0.000*

–14.893

0.000*

–11.439

0.000*

–14.211

0.000*

Figure 2: Scatter plot showing linear correlation between change in total SPADI score and SF-12 v2 overall score over 2 months of treatment

the large effect size (above 0.8) and ascertains the clinically
significant reduction of the SPADI score.

Medicines used

Overall in this study, 16 different medicines were prescribed
in 30cH,200cH and 1000cH potencies. The most frequently
indicated medicines were Rhus toxicodendron (n=7;17.5%),
Ferrum Metallicum (n=5;12.5%) and Syphilinum (n=5;12.5%)
[Figure 3].

Adverse or unanticipated events

Throughout the course of treatment, no unanticipated event
in the form of aggravation or worsening of symptoms, that is,

`adverse event’,[34,35] was reported by the participants either
directly in the OPD or over the phone.

Discussion
This study intended to explore the possible effects of IHM in
relieving pain, stiffness, reduction in limitation of movement
and disability in activities of daily life in the participants
suffering from AC. Upon throrough search, we realised there is
severe paucity of conclusive evidence-based homeopathy study
in the mainstream database for AC. We, therefore, devised a
study to come up with a single-arm clinical study to find some
effects of IHM on AC. AC, though a self-limiting condition, its
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Homoeopathic medicines prescribed
Rhus toxicodendron

7

Ferrum metallicum

5

Syphilinum

5

Lycopodium

4

Sanguinaria canadensis

4

Sepia

2

Sulphur

2

Mercurius solubilis

1

Natrum muriaticum

1

Arnica montana

1

Ignatia

1

Calcarea carbonica

1

Ruta

1

Medorrhinum

1

Arsenicum album

1

Pulsatilla

1

Natrum sulphuricum

1

Causticum

1
0

1

Frequency of prescribing

2

3

4

5

6

7

8

Figure 3: Homoeopathic medicines used: Sixteen different individualised medicines were prescribed in the clinical study

suffering may stretch for more than 3 years, leading to a serious
compromise along with the impaired psychosocial status
among the working section of the society.[8,37,38] This study
reflected a statistically significant result in the reduction of
pain, stiffness and improvement in limitation of the movement
of affected shoulder joints along with favourable improvement
in the QoL of the individuals suffering from AC. IHM was able
to reduce the pain, stiffness and limitation of movement within
a plausible time frame of 2 months which was the objective of
this study. The study also assessed the difference in response
before and after the administration of IHM in a single arm
of 36 participants suffering from AC. The validated outcome
such as SPADI and SF-12 v2 was taken as the primary and
ORIDL scores as secondary outcome measures, calculated,
respectively, at baseline and after 2 months of treatment.
To see the clinical significance between the baseline and
after 2 months of treatment, the effect size (Cohen’s-d) was
calculated from this primary outcome (SPADI score). The
obtained Cohen’s-d score (score ‘5.65’) [Table 3] indicates
the large effect size (above 0.8) and ascertains the clinically
significant reduction of the SPADI score.
A study of Magotra et al.[18] on AC used the SPADI and
Oxford Shoulder Score outcome measure to show the positive
effect of homoeopathy in AC. This study utilised the QoL
assessment scale measure like SF-12v2 along with the ACspecific rating scale to evaluate the effects of IHM. The prepost comparison study of SF-12v2 a well-validated Bengali
questionnaire showed changes in the outcomes over time
significantly. The significant correlation between SPADI a
36

Table 4: Non‑parametric correlation between patient
assessment and physician assessment of ORIDL score
Correlations

ORIDL score
physician
assessment

Spearman’s rho
ORIDL score physician assessment
Correlation coefficient
1.000
Sig. (two tailed)
144
n
ORIDL score patient assessment
Correlation coefficient
0.998**
Sig. (two tailed)
<0.001
144
n
**Correlation is significant at the 0.01 level (two tailed)

ORIDL score
patient
assessment

0.998**
<0.001
144
1.000
144

disease-specific rating scale and SF12 v2 also showed that
IHM when used in pursuance with homoeopathic principles
gives an overall improvement. We used the ORIDL scale to
detect the overall improvement of the participants in the realm
of participants and physician observation both. The correlation
between the changes in physician assessment ORIDL scores
and participants’ assessment ORIDL scores over 2 months
of treatment reflects that there is a significant correlation
that supports the overall timely improvement of the pain,
stiffness and QoL of the individual. However, AC participants
suffering from comorbidities [Table 1] were reported to be
low in terms of improvement in pain and stiffness. Altogether
authors were able to find only one such study Magotra et al.[18]
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where IHM had a possible effect on the systematic estimation
of results. Moreover, this study with a multidimensional
approach to measure perceived pain, stiffness, discomfort
and QoL along with the subjective measure of ORIDL has
been well-documented for the readers. AC responding with
IHM significantly within a reasonable time edge supported by
Magotra et al.[18] along with this study demands more robust
randomised controlled trials with a multicentre design in near
future. The strength of the study was following the approach
of model validity of homoeopathic treatment accompanying
all the six domains such as the rationale of the intervention,
principles of homoeopathy, practitioners experience, outcome
measures and outcome sensitivity along with the follow-up
of the condition treated.[39] The Bengali-translated version
of the SPADI questionnaires was able to elicit the minute
significant changes in the pain which was the primary outcome
measure in the study. The follow-up to evaluate the effects of
IHM which was for 2 months in this study was done to bring
in comparison with the conventional system of medicines
which can bring down the pain of AC within 3–4 weeks of
administration. The AC participants have to continue long
treatment along with supplements as in the conventional
system, which automatically brings in a disinterest and
accrues economic burden along with the chance of side effects
during the discourse.[7] In this study, the results were not only
statistically significant within the 2 months of follow-up but
also clinically with a large effect size. However, the study
missed the opportunity to find the role of IHT in radiological
changes in the affected joint and its assessment. The study if
conducted with control group and considering a large sample
size along with longer follow-up could further explore the
efficacy or effectiveness of the intervention which is warranted
in the future. This exploratory approach of the study without
incurring any major budgetary expenditure was a potential
explanation and its worthiness for further controlled trials.
The limitation of the study is that it is of one-group pretestposttest design, where measures such as blinding, randomisation
or control are missing, offers disadvantages of ruling out any
possible alternative explanations and poses a threat to their
validity.

Conclusion
This open-label, prospective one group of pretest-posttest
comparison design conducted on 40 subjects suffering from
AC showed statistically significant improvement in the
SPADI scale, SF-12 v2 health survey and ORIDL scores after
2 months of individualised homoeopathic treatment. Further
experimentations by adequately powered randomised trials and
independent replications with longer follow-ups are merited.
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Rôle de l’homéopathie dans la prise en charge de la capsulite adhésive: Une étude basée sur un modèle pré-test-post-test
RÉSUMÉ Contexte: La capsulite adhésive (CA) est un raidissement insidieux et douloureux de l’articulation gléno-humérale
(épaule), entraînant une diminution de la capacité fonctionnelle et de la qualité de vie (QOV). Objectifs: L’objectif principal était
d’évaluer l’évolution de la douleur à l’épaule après un traitement homéopathique individualisé sur 2 mois. L’objectif secondaire
était d’évaluer l’évolution de la qualité de vie et des résultats liés à l’impact sur la vie quotidienne (ORIDL). Méthodes: Une
étude clinique à un seul bras, de type pré-test-post-test, a été menée sur 40 participants souffrant de CA et fréquentant la clinique
externe des troubles rhumatologiques de l’unité de recherche clinique (homéopathie), à Siliguri, au Bengale occidental, en
Inde. Les médicaments ont été prescrits sur la base de l’ensemble des symptômes. L’évolution de la douleur à l’épaule sur 2
mois a été évaluée à l’aide de l’indice de douleur et d’incapacité à l’épaule (SPADI). La qualité de vie a été évaluée à l’aide du
SF-12v2 et de l’ORIDL (évalués par les participants et les médecins), respectivement. Résultats: 36 participants ont terminé
l’étude et quatre participants ont abandonné. Un échantillon conforme au protocole de (n = 36) a été analysé. On a constaté une
réduction statistiquement significative du score SPADI (91,92 ± 10,22 contre 34,14 ± 24,43 ; réduction moyenne de 57,78, IC
95 % 49,41-66,14, P < 0,001) et une augmentation statistiquement significative du score SF-12 v2 (44,39 ± 9,70 contre 72,27 ±
10,97 ; augmentation moyenne de 27,87, IC 95 % 23,89-31,85, P < 0,001). La corrélation de Spearman entre les changements
dans les scores ORIDL évalués par les médecins et les scores ORIDL évalués par les participants sur une période de 2 mois a
suggéré une corrélation statistiquement significative (rs = 0,998, P < 0,01). Conclusion: Les résultats ont montré une atténuation
des symptômes et une amélioration de la qualité de vie après le traitement homéopathique. Des essais contrôlés randomisés
sont encore nécessaires.

Die Rolle der Homöopathie bei der Behandlung der adhäsiven Kapsulitis: Eine Studie mit Prä-Test-Post-Test-Design
Abstrakt Hintergrund: Die adhäsive Kapsulitis (AC) ist eine schleichende und schmerzhafte Versteifung des Schultergelenks, die
zu einer Beeinträchtigung der Funktionsfähigkeit und der Lebensqualität führt. Zielsetzungen: Primäres Ziel war die Bewertung
der Veränderung der Schulterschmerzen nach einer individualisierten homöopathischen Behandlung über 2 Monate. Sekundäres
Ziel war die Bewertung der Veränderung der Lebensqualität und des Ergebnisses in Bezug auf die Auswirkungen auf das tägliche
Leben (ORIDL). Methoden: Eine einarmige klinische Prä-Test-Post-Test-Studie wurde mit 40 Teilnehmern durchgeführt, die
an AC litten und die Ambulanz für rheumatologische Erkrankungen in der Clinical Research Unit (Homöopathie), Siliguri,
Westbengalen, Indien, aufsuchten. Die Medikamente wurden auf der Grundlage der Gesamtheit der Symptome verschrieben. Die
Veränderungen der Schulterschmerzen über 2 Monate wurden anhand des Schulterschmerz- und Behinderungsindex (SPADI)
bewertet. Die Lebensqualität wurde anhand des SF-12v2 und des ORIDL (nach Einschätzung der Teilnehmer und des Arztes)
bewertet. Ergebnisse: 36 Teilnehmer schlossen die Studie ab, vier Teilnehmer brachen sie ab. Es wurde eine protokollkonforme
Stichprobe von (n = 36) analysiert. Es gab eine statistisch signifikante Verringerung des SPADI-Scores (91,92 ± 10,22 vs. 34,14
± 24,43; mittlere Verringerung 57,78, 95% CI 49,41-66,14, P < 0,001) und eine statistisch signifikante Erhöhung des SF-12 v2Scores (44,39 ± 9,70 vs. 72,27 ± 10,97; mittlere Erhöhung 27,87, 95% CI 23,89-31,85, P < 0,001). Die Spearman-Korrelation
zwischen den Veränderungen der ORIDL-Scores nach ärztlicher Beurteilung und den ORIDL-Scores nach Einschätzung
der Teilnehmer über einen Zeitraum von 2 Monaten deutete auf eine statistisch signifikante Korrelation hin (rs = 0,998, P <
0,01). Schlussfolgerung: Die Ergebnisse zeigen eine Linderung der Symptome und eine Verbesserung der Lebensqualität nach
homöopathischer Behandlung. Randomisierte kontrollierte Studien sind weiterhin gerechtfertigt.
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आसंजी सम्पुटशोध के प्रबंधन में होम्योपैथी की भूमिका: एक परीक्षण-पूर्व परीक्षण-पश्चात डिजाइन-आधारित अध्ययन
पृष्ठभूमि: आसंजी सम्पुटशोध (एसी) ग्लेनोहुमरल (कंधे) के जोड़े का एक विकट और दर्द नाक कड़ापन है , जिसके परिणामस्वरूप समझौता
कार्यात्मक क्षमता और जीवन की गुणवत्ता (क्यूओएल) जोखिमपूर्ण होती है । उद्दे श्य: प्राथमिक उद्दे श्य 2 महीने में व्यक्तिगत होम्योपैथी
उपचार के बाद कंधे के दर्द में परिवर्तन का मूल्यां कन करना था। द्वितीयक उद्दे श्य क्यूओएल में परिवर्तन और दै निक जीवन पर प्रभाव
(ओआरआईडीएल) से संबंधित परिणाम का आकलन करना था। विधियां: नैदानिक अनुसंधान इकाई (होम्योपैथी), सिलीगुड़ी, पश्चिम बंगाल,
भारत में रुमेटोलॉजिकल विकारों के आउट पेशेंट क्लिनिक में भाग लेने वाले एसी से पीड़ित 40 प्रतिभागियों पर एक एकल-शाखा पूर्वपरीक्षण-परीक्षण-पश्चात-जां च नैदानिक अध्ययन आयोजित किया गया था। लक्षणों की समग्रता के आधार पर दवाएं निर्धारित की गई थीं।
2 महीने से अधिक समय तक कंधे के दर्द में परिवर्तन का मूल्यां कन कंधे के दर्द और विकलां गता सूचकां क (एसपीएडीआई) का उपयोग
करके किया गया था। क्यूओएल का मूल्यां कन क्रमशः एसएफ-12वी2 और ओआरआईडीएल (प्रतिभागियों और चिकित्सक का मूल्यां कन)
का उपयोग करके किया गया था। परिणाम: 36 प्रतिभागियों ने अध्ययन पूरा किया और चार प्रतिभागियों ने छोड़ दिया। (एन = 36) के एक
प्रोटोकॉल अनुरूप नमूने का विश्लेषण किया गया था। एसपीएडीएल स्कोर (91.92 ± 10.22 बनाम 34.14 ± 24.43; औसत कमी 57.78,
95% सीआई 49.41-66.14, पी <0.001) और एसएफ -12 वी 2 स्कोर मे में सां ख्यिकीय रूप से महत्वपूर्ण वृद्धि हुई थी (44.39 ± 9.70
बनाम 72.27 ± 10.97) औसत वृद्धि 27.87, 95% सीआई 23.89-31.85, पी<0,001। चिकित्सक मूल्यां कन ओआरआईडीएल स्कोर में
परिवर्तन और प्रतिभागियों के मूल्यां कन ओआरआईडीएल स्कोर में परिवर्तन के बीच एसपियर के सहसंबंध ने 2 महीने में एक सां ख्यिकीय
रूप से महत्वपूर्ण सहसंबंध का सुझाव दिया (आरएस = 0.998, पी <0.01)। निष्कर्ष: निष्कर्षों ने होम्योपैथिक उपचार के बाद क्यूओएल
में लक्षण उन्मूलन और सुधार दिखाया। यादृच्छिक नियंत्रित परीक्षणों को आगे वारं ट किया जाता है ।
Papel de la homeopatía en el tratamiento de la capsulitis adhesiva: un estudio basado en el diseño pre - prueba - post – prueba
Abstracto El antecedente: La capsulitis adhesiva (CA)es un endurecimiento insidioso y doloroso de la articulación glenohumeral
(hombro), lo que resulta en una capacidad funcional comprometida y en la calidad de vida (CdV). Objetivos: El objetivo
principal fue evaluar el cambio en el dolor de hombro después del tratamiento individualizado de la homeopatía durante 2 meses.
El objetivo secundario fue evaluar el cambio en la CdV y el resultado relacionado con el impacto en la vida diaria (ORIDL).
Métodos: Se realizó un estudio clínico de un solo brazo pre - prueba - post – pruebaen 40 participantes con AC que acudieron
a la clínica ambulatoria de trastornos reumatológicos de la Unidad de Investigación Clínica (Homeopatía), Siliguri, Bengala
Occidental, India.Los medicamentos se recetaron sobre la base de la totalidad de los síntomas. Los cambios en el dolor de hombro
durante 2 meses se evaluaron mediante el índice de dolor de hombro y discapacidad (SPADI).La QOL se evaluó utilizando
SF-12v2 y ORIDL (participantes y médico evaluados), respectivamente. Resultados: 36 participantes completaron el estudio y
cuatro abandonaron el estudioSe analizó una muestra conforme al protocolo de (n = 36). Hubo una reducción estadísticamente
significativa de la puntuación de SPADI (91,92 ± 10,22 vs. 34,14 ± 24,43; reducción media 57,78, IC 95% 49,41–66,14, P <
0,001) y un aumento estadísticamente significativo de la puntuación de SF-12 v2 (44,39 ± 9,70 vs. 72,27 ± 10,97; aumento
medio 27,87, IC 95% 23,89–31,85, P < 0,001).La correlación de Spearman entre los cambios en las puntuaciones ORIDL de
la evaluación médica y las puntuaciones ORIDL de la evaluación de los participantes durante 2 meses sugirió una correlación
estadísticamente significativa (rs = 0,998, P < 0,01). Conclusión: Los hallazgos mostraron alivio y mejoría de los síntomas en
el QoLdespués del tratamiento homeopático.Los ensayos controlados aleatorios están además justificados.

顺势疗法在治疗粘连性关节炎中的作用: 一个基于前测后测设计的研究
摘要
背景介绍: 粘连性关节囊炎（AC）是一种隐性的、痛苦的盂肱关节（肩）僵化，导致功能能力和生活质量（QoL）受
到影响。).
目标:主要目标是评估个体化同济疗法治疗后2个月内肩部疼痛的变化。次要目标是评估QoL的变化和对日常生活影响
的结果（ORIDL).
方法:在印度西孟加拉邦西里古里的临床研究单位（顺势疗法）的风湿病门诊，对40名患有AC的参与者进行了单臂
前测后测的临床研究。药品的处方是根据全部症状来决定的. 使用肩痛和残疾指数（SPADI）评估2个月内的肩痛变
化。QoL是用SF-12v2和ORIDL（参与者和医生评估）分别进行评估的。.
结果: 36名参与者完成了研究，4名参与者退出了研究。对符合协议的样本（n = 36）进行了分析。在统计学上，SPADI
得分有显著下降（91.92 ± 10.22 vs. 10.22）。. 34.14±24.43；平均减少57.78，95%CI49.41-66.14，P＜0.001），SF-12 v2
得分有统计学意义的增加 （44.39±9.70 vs. 72.27±10.97；平均增加27.87，95%CI 23.89-31.85，P＜0.001）。医生评估的
ORIDL分数的变化和参与者评估的ORIDL分数在2个月内的斯皮尔曼斯相关性表明有统计学意义的相关性（rs = 0.998,
P < 0.01）。.
总结:研究结果显示，同济疗法治疗后，症状得到缓解，QoL得到改善。有必要进一步进行随机对照试验。.
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